Form 4: Natera CFO Sells Over 5,000 Shares in Planned Trades

Natera's Chief Financial Officer Michael Brophy disposed of 5,063 shares through tax-related obligations and a pre-arranged trading plan.

Summary

• Chief Financial Officer Michael Burkes Brophy sold a total of 5,063 shares of Natera, Inc. (NTRA) common stock between April 27 and April 29, 2026.
• The transactions were executed in multiple tranches with prices ranging from $190.115 to $204.39 per share.
• A portion of the sales (1,993 shares) was conducted specifically to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• The remaining 3,070 shares were sold under a Rule 10b5-1 trading plan, which was originally adopted on June 9, 2025, and amended on September 5, 2025.
• Following these transactions, the CFO continues to hold a direct ownership of 58,291 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing. The sales were largely automated for taxes or pre-planned, and the CFO retains a significant majority of his equity stake.

Positives

• The CFO maintains a substantial direct ownership stake of 58,291 shares, aligning interests with shareholders.
• The majority of the sales were pre-planned under a Rule 10b5-1 trading plan, which helps mitigate concerns regarding opportunistic insider trading.
• A significant portion of the disposal was non-discretionary, intended solely to cover tax liabilities from equity compensation vesting.

Negatives

• The sale of 5,063 shares represents a reduction in the executive's total direct holdings.
• The sales occurred at varying price points, with some tranches executed as low as $190.115, significantly lower than the $204.39 peak seen earlier in the week.

Risks

• Market perception of insider selling can occasionally lead to short-term downward pressure on the stock price.
• The reliance on automated trading plans means sales may occur during periods of high volatility or unfavorable market conditions.

Future Outlook

The filing indicates continued execution of a pre-arranged trading plan, suggesting that further scheduled sales may occur in the future as part of the executive's long-term financial planning.

Management Comments

• The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.
• The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Industry Context

StockSavvy.ai notes that regular insider sales for tax purposes and diversification are standard practice among executives in the high-growth biotechnology and diagnostics sectors, particularly following significant stock price appreciation.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a best-practice standard for corporate governance among NASDAQ-listed companies like Natera.
• The volume of the sale relative to total holdings is consistent with typical executive diversification strategies seen at peer companies such as Exact Sciences or Guardant Health.

Related Party Transactions

• The reporting person, Michael Brophy, is the Chief Financial Officer of the issuer, Natera, Inc.

Stakeholder Impact

• Shareholders may see a minor increase in market liquidity for the stock.
• The transparency of the 10b5-1 plan provides assurance to investors that the sales are not based on non-public material information.

Next Steps

• Monitor future Form 4 filings for continued sales under the September 2025 amended trading plan.

Key Dates

Recommendation

The transactions are routine and pre-planned, reflecting standard executive compensation management rather than a shift in company fundamentals or management's outlook on the business.

Keywords

Natera, NTRA, Insider Trading, CFO, Michael Brophy, Rule 10b5-1, Restricted Stock Units, Common Stock, Tax Withholding